Fig. 5From: Lanthanum-based metal organic framework (La-MOF) use of 3,4-dihydroxycinnamic acid as drug delivery system linkers in human breast cancer therapyPlots of percentage of cytotoxicity vs. concentrations of the 3,4-DHCA (0–100.0 μM) and La-based MOF (0–100.0 μM) against human breast cancer cells after incubation for 48 hBack to article page